Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001172661-26-001266·AGIOS PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
Agios Pharmaceuticals Inc
Common stock, par value $0.0001 per share · CUSIP: 00847X104
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Armistice Capital, LLC
Shares: 3,036,000.00 · Class: 5.21%
- Steven Boyd
Shares: 3,036,000.00 · Class: 5.21%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-26-001266
- Form type
- SCHEDULE 13G
- Filer
- AGIOS PHARMACEUTICALS, INC.
- CIK
- CIK 1439222
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership